[go: up one dir, main page]

NO20022600L - Nye heterocykliske forbindelser og salter derav og medisinsk anvendelse av samme - Google Patents

Nye heterocykliske forbindelser og salter derav og medisinsk anvendelse av samme

Info

Publication number
NO20022600L
NO20022600L NO20022600A NO20022600A NO20022600L NO 20022600 L NO20022600 L NO 20022600L NO 20022600 A NO20022600 A NO 20022600A NO 20022600 A NO20022600 A NO 20022600A NO 20022600 L NO20022600 L NO 20022600L
Authority
NO
Norway
Prior art keywords
salts
same
heterocyclic compounds
medical use
new heterocyclic
Prior art date
Application number
NO20022600A
Other languages
English (en)
Other versions
NO20022600D0 (no
NO323922B1 (no
Inventor
Hiroshi Matsui
Hideo Kobayashi
Satoru Azukizawa
Masayasu Kasai
Akihisa Yoshimi
Hiroaki Shirahase
Original Assignee
Kyoto Pharma Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyoto Pharma Ind filed Critical Kyoto Pharma Ind
Publication of NO20022600D0 publication Critical patent/NO20022600D0/no
Publication of NO20022600L publication Critical patent/NO20022600L/no
Publication of NO323922B1 publication Critical patent/NO323922B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20022600A 1999-12-03 2002-05-31 Heterosykliske forbindelser og farmasoytisk middel omfattende samme NO323922B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP34554399 1999-12-03
JP2000295108 2000-09-27
PCT/JP2000/008464 WO2001040192A1 (en) 1999-12-03 2000-11-29 Novel heterocyclic compounds and salts thereof and medicinal use of the same

Publications (3)

Publication Number Publication Date
NO20022600D0 NO20022600D0 (no) 2002-05-31
NO20022600L true NO20022600L (no) 2002-08-05
NO323922B1 NO323922B1 (no) 2007-07-23

Family

ID=26578048

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022600A NO323922B1 (no) 1999-12-03 2002-05-31 Heterosykliske forbindelser og farmasoytisk middel omfattende samme

Country Status (20)

Country Link
US (1) US6589963B2 (no)
EP (1) EP1236719A4 (no)
KR (1) KR100716525B1 (no)
CN (1) CN1215059C (no)
AR (1) AR033349A1 (no)
AU (1) AU782631C (no)
BR (1) BR0016064A (no)
CA (1) CA2393265A1 (no)
CO (1) CO5440230A1 (no)
CZ (1) CZ20021911A3 (no)
HU (1) HUP0203431A3 (no)
IL (2) IL149883A0 (no)
MX (1) MXPA02005528A (no)
NO (1) NO323922B1 (no)
NZ (1) NZ519592A (no)
PL (1) PL356769A1 (no)
RU (1) RU2256661C2 (no)
TW (1) TWI286549B (no)
WO (1) WO2001040192A1 (no)
YU (1) YU50302A (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455734B1 (en) * 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
ES2274013T3 (es) 2001-01-26 2007-05-16 Schering Corporation Combinaciones de activador(es) del receptor activado por el proliferador de los peroxisomas (ppar) e inhibidor(es)m de la absorcion de estelores y tratamientos para trastornos vasculares.
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
EP1911462A3 (en) 2001-01-26 2011-11-30 Schering Corporation Compositions comprising a sterol absorption inhibitor
CA2434430A1 (en) 2001-01-26 2002-08-01 Harry R. Davis The use of substituted azetidinone compounds for the treatment of sitosterolemia
CZ20033450A3 (cs) 2001-05-29 2004-05-12 Kyotoápharmaceuticaláindustriesźáltd Heterocyklická sloučenina a její lékařské použití
RU2287529C2 (ru) * 2001-05-29 2006-11-20 Киото Фармасьютикал Индастриз, Лтд. Новые гетероциклические производные и их медицинское использование
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
AU2002336609B2 (en) 2001-09-21 2006-08-24 Merck Sharp & Dohme Corp. Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
AU2003203170A1 (en) * 2002-01-17 2003-07-30 Takeda Chemical Industries, Ltd. Nitrogenous heterocyclic compounds, process for preparation of the same and use thereof
DE10222034A1 (de) * 2002-05-17 2003-11-27 Bayer Ag Tetrahydroisochinolin-Derivate
WO2004043457A1 (en) 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
PA8594401A1 (es) * 2003-02-21 2004-09-16 Pfizer Acidos carboxilicos de heteroarilo condensado como agonista del ppar
CN1756756A (zh) 2003-03-07 2006-04-05 先灵公司 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
US7235543B2 (en) 2003-03-07 2007-06-26 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
WO2004081004A1 (en) 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
CN1300115C (zh) * 2004-03-26 2007-02-14 厦门大学 一种合成1，2，3，4－四氢异喹啉衍生物的方法
DK1805158T3 (en) 2004-10-29 2018-08-06 Kalypsys Inc SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS MODULATORS OF PPAR
KR20080027923A (ko) * 2005-08-08 2008-03-28 화이자 인코포레이티드 Ｖｅｇｆ-ｒ 억제제의 염 및 다형체
CN101304992A (zh) * 2005-09-07 2008-11-12 普莱希科公司 用作ppar调节剂的1,3-二取代吲哚衍生物
US7790745B2 (en) 2005-10-21 2010-09-07 Bristol-Myers Squibb Company Tetrahydroisoquinoline LXR Modulators
WO2007051095A1 (en) * 2005-10-25 2007-05-03 Kalypsys, Inc. Salts of modulators of ppar and methods of treating metabolic disorders
EP1790646A1 (fr) * 2005-11-24 2007-05-30 Sanofi-Aventis Derives de Isoquinoline et Benzo[h]Isoquinoline, leur preparation et leur utilisation en thérapeutique en tant qu'antagonistes du recepteur de l'histamine H3.
WO2008091863A1 (en) 2007-01-23 2008-07-31 Kalypsys, Inc. Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis
US20080186971A1 (en) * 2007-02-02 2008-08-07 Tarari, Inc. Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
WO2009019598A2 (en) * 2007-08-03 2009-02-12 Dr. Reddy's Laboratories Ltd. Inhalation therapy for respiratory disorders
BRPI0910282A2 (pt) * 2008-03-07 2015-09-01 Transtech Pharma Inc Composto oxadiazo-antraceno para o tratamento de diabetes
AR080375A1 (es) 2010-03-05 2012-04-04 Sanofi Aventis Procedimiento para la preparacion de 2-(cicloheximetil)-n-{2-[(2s)-1-metilpirrolidin-2-il] etil}-1,2,3,4-tetrahidroisoquinolina- 7-sulfonamida
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
WO2012033195A1 (ja) * 2010-09-10 2012-03-15 京都薬品工業株式会社 複素環化合物
CN102807526B (zh) * 2011-06-21 2015-12-02 寿光富康制药有限公司 组蛋白去乙酰化酶抑制剂ZYJ-D08a及其差向异构体的制备方法与应用
CN102702098A (zh) * 2012-05-24 2012-10-03 盛世泰科生物医药技术(苏州)有限公司 6-甲氧基-1,2,3,4四氢喹啉-5羧酸甲酯的合成
AR101196A1 (es) * 2014-07-16 2016-11-30 Gruenenthal Gmbh Compuestos de pirimidina sustituidos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6051189A (ja) 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
AR240698A1 (es) 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
DE10199003I1 (de) 1987-09-04 2003-06-12 Beecham Group Plc Substituierte Thiazolidinionderivate
US5246943A (en) * 1992-05-19 1993-09-21 Warner-Lambert Company Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties
GB9604242D0 (en) * 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
CA2259431A1 (en) 1996-07-01 1998-01-08 Eli Lilly And Company Hypoglycemic and hypolipidemic compounds
IL121202A (en) * 1996-07-01 2001-08-26 Lilly Co Eli Hypoglycemic and hypolipidemic compounds, process for their preparation, pharmaceutial compositions comprising same, and uses thereof

Also Published As

Publication number Publication date
RU2256661C2 (ru) 2005-07-20
NO20022600D0 (no) 2002-05-31
CA2393265A1 (en) 2001-06-07
HUP0203431A3 (en) 2003-11-28
BR0016064A (pt) 2004-07-27
WO2001040192A1 (en) 2001-06-07
KR20020058079A (ko) 2002-07-12
TWI286549B (en) 2007-09-11
EP1236719A4 (en) 2003-06-25
IL149883A (en) 2007-03-08
HK1053657A1 (en) 2003-10-31
AU1649501A (en) 2001-06-12
IL149883A0 (en) 2002-11-10
AU782631B2 (en) 2005-08-18
CN1215059C (zh) 2005-08-17
EP1236719A1 (en) 2002-09-04
PL356769A1 (en) 2004-07-12
NO323922B1 (no) 2007-07-23
NZ519592A (en) 2003-11-28
CO5440230A1 (es) 2004-09-30
KR100716525B1 (ko) 2007-05-10
YU50302A (sh) 2006-01-16
AU782631C (en) 2006-08-17
HUP0203431A2 (hu) 2003-02-28
MXPA02005528A (es) 2002-09-02
AR033349A1 (es) 2003-12-17
US20030027836A1 (en) 2003-02-06
US6589963B2 (en) 2003-07-08
CZ20021911A3 (cs) 2002-10-16
CN1402712A (zh) 2003-03-12

Similar Documents

Publication Publication Date Title
NO20022600D0 (no) Nye heterocykliske forbindelser og salter derav og medisinsk anvendelse av samme
NO20020180L (no) Nye kinuklidinderivater og medisinske sammensetninger inneholdende det samme
NO20022289L (no) Ny anvendelse og nye N-azabisykloamidderivater
NO20033002L (no) Nye kinuklidinderivater og medisinske sammensetninger inneholdende det samme
DE50009607D1 (de) Substituierte oxazolidinone und ihre verwendung im gebiet der blutgerinnung
NO20014950D0 (no) Nye behandlingsmetoder
DE60020701D1 (de) Thiazol- und oxazol-derivate und ihre pharmazeutische verwendung
NO20021811D0 (no) Nye oksabispidinforbindelser som er nyttige i behandlingen av hjertearrytmier
NO20022087L (no) Fremgangsmåte for behandling av diabetes
SI1231920T1 (sl) Uporaba epinastina za zdravljenje alergijskega renitisa/konjuktivitisa
NO20015542D0 (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
NO20044250L (no) Heterocykliske amid-derivativer for behandling av diabetes og andre sykdommer
IL161854A0 (en) Heterocyclic derivatives of glycinamide and their medical use
NO20035332D0 (no) Nye heterocykliske derivater og medisinsk anvendelse derav
NO20054535D0 (no) Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme
NO20035331D0 (no) Nye heterocyklisk forbindelse og medisinsk anvendelse derav
AU2002308891A1 (en) Novel heterocyclic derivatives and medicinal use thereof
NO20015738L (no) Terapeutisk bruk av melatonin
NO20020784D0 (no) Medikament for behandling av brudd
EP1137412A4 (en) SUBSTITUTED NITROGEN HETEROCYCLIC COMPOUNDS AND THEIR THERAPEUTIC USE
EE200100381A (et) Morfolinobensamiidi uued soolad
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
NO20016117D0 (no) Nye bispidinforbindelser som er nyttige i behandlingen av hjertearytmier
NO20016127L (no) Nye bisbidinforbindelser som er nyttige i behandlingen av hjertearytmier
NO20014026L (no) Krampestillende derivater til behandling av betydelig skjelving